European Psychiatry - Volume 41 - April 2017

136 / 916

S132 25th European Congress of Psychiatry / European Psychiatry 41S (2017) S106–S169
Methods Parents, enrolled in the Odense Child Cohort (OCC),
answered the CBCL/1½–5 when the child reached 27 months of
age. Parents with children above the age of four and a raw score ≥5
(90th percentile) on the PDP scale, received the Social Responsive-
ness Scale (SRS) questionnaire. Children with a high score on the
SRS were invited to a clinical examination consisting of ADOS and
ADI-R. Children in OCC were re-assessed with CBCL/1½–5 again at
age five years.
Results Results will be presented at the EPA conference 2017 in
Florence.
Conclusions The results may contribute to enhance the outcome
of treatment by detecting children with ASD at an earlier age.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
e-Poster walk: Co-morbidity/dual pathologies and
guidelines/Guidance – part 1
EW0080
Prevalence and predictors of ADHD
symptoms in adults admitted for
substance use disorder treatment:
A prospective cohort study
K. Abel ∗, E. Ravndal , T. Clausen , J. Bramness
Norwegian Center for Addiction Research SERAF, University of Oslo,
Faculty of Medicine, Oslo, Norway
∗ Corresponding author.
Introduction Substance use disorders (SUD) are common in
adults with ADHD. A co-occurring ADHD diagnosis is associated
with poorer treatment outcomes for both the ADHD and the SUD
and higher rates of relapse to substance use.
Objectives To explore the relationship between ADHD and SUD
longitudinally to identify factors to help improve treatment out-
comes.
Aims Prevalence of ADHD symptoms was investigated in a
national cohort of SUD patients one year after SUD treatment initia-
tion. Factors at baseline related to ADHD symptoms were explored
at follow up.
Methods Five hundred and forty-eight individuals were inter-
viewed in a multi-center study involving 21 treatment facilities at
treatment initiation and one year later (n = 261). ADHD symptoms
were measured by the Adult ADHD Self Report Scale (ASRS-v.1-
1) at follow-up. Individuals who screened positively for ADHD
(ADHD + ) were compared to those who screened negatively on
baseline variables. Emotional distress was measured by Hopkin’s
Symptom Check List-25.
Results At follow-up 35% screened positively for ADHD. In bivari-
ate analysis the ADHD+ group was older, was less likely to have
children, reported lower educational level, had more frequent
use of stimulants, cannabis and benzodiazepines, and experienced
higher degree of emotional stress. When controlling for other sig-
nificant variables in a logistic regression analysis, the ADHD+ group
was associated with more frequent use of cannabis (OR 2.14; CI
1.08–4.23) and of higher psychiatric symptom burden (OR 1.79; CI
1.22–2.61).
Conclusions A high prevalence of ADHD symptoms and associ-
ated challenges underline the importance of systematic screening
of individuals entering SUD treatment.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EW0081
The duration of undiagnosed bipolar
disorder: Impact of substance use
disorders co-morbidity
S. Ben Mustapha ∗, W. Homri , L. Jouini , R. Labbane
Razi Hospital, service de psychiatrie C, Mannouba, Tunisia
∗ Corresponding author.
Aims Study the impact of substance use disorders (SUD) co-
morbidity on the duration of undiagnosed bipolar disorder (DUBP).
Methods Case-control study during a period of six months from
July 2015 to December 2015. One hundred euthymic patients with
BD (type I, II or unspecified) were recruited in the department of
psychiatry C Razi Hospital, during their follow-up. Two groupswere
individualized by the presence or not of a SUD co-morbidity. In our
study DUBP was defined as the period between the first symptoms
and the beginning of treatment by a mood stabilizer.
Results The beginning of addictive behaviour preceded the instal-
lation of bipolar disease in 32% of cases. Installation of bipolar
disorder preceded the installation of addictive behaviour in 12% of
cases. The beginning of addictive behaviour was concomitant with
the installation of bipolar disease in 6% of cases. The average DUBP
in the full sample was 4.80 years with a standard deviation of 8.04
and extremes ranging from 0.08 to 37.5.
The average DUBP in patients with SUD co-morbidity was 5.91
years with a standard deviation of 8.16 and extremes ranging from
0.08 to 35, and 3.68 years with a standard deviation of 7.84 and
extremes ranging from 0.08 to 37.5 in patients without SUD co-
morbidity.
Conclusions According to studies over two thirds of patients with
bipolar disorder received misdiagnoses before diagnosis of BD,
and among the factors involved can report the presence of SUD
co-morbidity. Hence, we should detect BD among patients with
SUD.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EW0082
Smoking, preparing the patient with
a severe mental disorder for change
G.M. Chauca Chauca ∗, M.J. Jaén Moreno , M.I. Osuna Carmona ,
J.A. Alcalá Partera , A.B. Rico del Viejo , F. Sarramea Crespo
1 Instituto Maimónides de Investigación Biomédica de Córdoba.
Hospital Infanta Margarita, Universidad de Córdoba, Cabra, Córdoba,
Spain
2 Instituto Maimónides de Investigación Biomédica de Córdoba
IMIBIC, Hospital Universitario Reina Sofía. Universidad de Córdoba,
Córdoba, Spain
3 Instituto Maimónides de Investigación Biomédica de Córdoba
IMIBIC, Hospital Universitario Virgen de la Victoria.
USMC-Fuengirola. Universidad de Córdoba, Córdoba, Spain
∗ Corresponding author.
Introduction Smoking is a serious health problem for people with
mental illness like the bipolar disorder patients. The developmental
of motivational tools such as brief intervention it is necessary in the
context of community care.
Objectives Evaluating the change inmotivational stage after brief
intervention and evaluating the clinical and smoking factors in rela-
tion with this.
Methods Two hundred and twenty patients diagnosedwith bipo-
lar disorder (according DSM-5 criteria) that were in the euthymic
phase (defined as less than 7 points in YMRS and 10 points in HDRS)
and attended the community care centers of three provinces of
Andalusia (Spain). Patients who consumed in the last month qual-
ified for the level of motivation for change (measured by URICA
scale).